Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

Novartis’ Cosentyx beats Stelara in psoriasis study

Cosentyx achieved clearance in 70% of patients

- PMLiVE

A difficult journey

The pursuit of excellence in key account management

- PMLiVE

Cancer Drugs Fund is not NICE replacement

Malcolm Qualie, pharmacy lead for specialised services within NHS England, speaks to PMLiVE

Bristol-Myers Squibb (BMS) building

Opdivo to be tested as ‘double immunotherapy’ for tumours

BMS and Ono to test anti-PD-1 in combination with Kyowa Hakko's mogamulizumab

- PMLiVE

Merck to start major trial of Keytruda in breast cancer

PD-1 immunotherapy is already available as treatment for melanoma

- PMLiVE

Kim Lemon appointed head of Liberation Unlimited

Will lead rebrand of Communiqué award-winning agency

Paolo Casati named as general manager of Santen Italy

Has over 30 years of experience in the sector

- PMLiVE

Cello Health acquires market research firm Promedica

Move is the group’s second acquisition of the year

- PMLiVE

Alzheimer’s charity launches £20m trials fund

Aims to fast-track research into dementia treatments

- PMLiVE

Don’t forget email in your marketing strategy

Could it be the most underrated marketing channel in pharma?

Pfizer taps mobile app for patient recruitment

Looks to use smartphone technology to identify rare disease patients

- PMLiVE

UK Labour party pledges £330m cancer fund

Says will improve access to cancer drugs, radiotherapy and surgery if elected

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links